I guess after the head of terms to sell 70% of existing and future bioenergy projects the 2M EBITDA target probably will become not relevant for this year. My understanding is RNE is trading off near term profit for much larger future profit. The good part of the term is that funding will be easier to access for future project opportunities. So they don't need to go out to find funding or ask shareholder for each project. Correct me if I am mistaken.
RNE Price at posting:
1.3¢ Sentiment: Buy Disclosure: Held
